VERA — Vera Therapeutics Inc.

Ownership history in MPM BioImpact LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Vera Therapeutics Inc. (VERA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.68% (2025 Q3)
Avg. % of fund
2.06%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 563,075 — 0% 2.68% $16.4M $29.06
2025 Q2 ADDED 563,075 +147,356 +35.4% 2.30% $13.3M $23.56
2025 Q1 ADDED 415,719 +157,931 +61.3% 1.72% $10.0M $24.02
2024 Q4 INITIATED 257,788 — — 1.55% $10.9M $42.29
% of Fund (quarterly)    VERA price (monthly, adj. close)

Other funds also holding VERA

As of 2025 Q4 — sorted by position size

Kynam Capital Management, LP 3Y 11.11% Eversept Partners, LP 3Y 7Y 7.84% Elmind Capital, LP 7.21% Sofinnova Investments, Inc. 3Y 7Y 6.1% Tri Locum Partners LP 3Y 5.3% Integral Health Asset Management, LLC 3Y 4.53% First Turn Management, LLC 3.48% First Light Asset Management, LLC 3Y 7Y 3.37% Exome Asset Management LLC 3.01% Avoro Capital Advisors LLC 3Y 7Y 2.93%
← Back to MPM BioImpact LLC Holdings